Skip to Content
Patient Information Leaflets (PILs)

These Patient Information Leaflets (PILs) are specially written by the British Association of Dermatologists (BAD). A small selection is available in booklet format and can be ordered by filling in an order form.

The BAD has been awarded The Information Standard certification for the process it employs to develop information products aimed at the general public, which include PILs, Sun Awareness Campaign materials, and other information products.

The BAD shall hold responsibility for the accuracy of the information published, and neither the scheme operator nor the scheme owner shall have any responsibility for costs, losses, or direct or indirect damages or costs arising from inaccuracy of information or omissions in information published on the website on behalf of the BAD.

Close
Azathioprine

Azathioprine has been available since the 1960s. It was developed initially to stop rejection of transplanted organs, such as kidneys. It is now used to treat a wide range of illnesses. It works by suppressing the body’s own defence system (the immune system), either by itself or in combination with other drugs. Azathioprine is not a steroid and is considered to be safer in the long-term than steroid tablets.

Back to top